维普期刊资源整合服务平台（V6.5）

31篇 您的检索式：作者名="Selwyn D"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end points 显示文摘	Kinaly S Selwyn AP Delagrange D	1996	Curr Opin Lipidol1996，7，：	1
2	Patterns of cell death in freshwater colonial cyanobacteria during the late summer bloom 显示文摘	Sigee D C Selwyn A Gallois P	2007	Phycologia2007，46，：	1
3	Biological mechanismsf or the clinical success of lipid-low ering in coronary artery disease and the use of surrogate end points 显示文摘	Kinlay S Selwyn AP Delagrange D	1996	Curr Opin Lipidol1996，，7：	1
4	Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection 显示文摘	Selwyn PA Alcabes P Hartel D	1992	N Engl J Med1992，327，24：	1
5	Risk factors forhuman inununodeficieney virus io-feetion in intravenous drug users 显示文摘	Schoenbaum EE Hartel D Selwyn PA	1989	NEnglJMed1989，321，13：	1
6	A prospectivestudy of the risk of tuberculosis among intravenous drug userswith human immunodeficiency virus infection显示文摘	Selwyn PA HHAARTel D Lewis VA	1989	N Engl J Med1989，320，9：	1
7	Biological mechanisms for the clinical success of lipid - lowering in coronary artery disease and the use of surrogate end points 显示文摘	Selwyn AP Delagrange D	1996	Curr Opin Lipidol1996，7，：	1
8	A prospective study of therisk of tuberculosis among intravenous drug users with human im-munodeficiency virus infection显示文摘	Selwyn PA Hartel D Lewis VA	1989	N Engl J Med1989，320，9：	1
9	Biological mechanisms for the clinical success of lipidlowering in coronary artery disease and the use of surrogate endpoints 显示文摘	Kinlay S Selwyn AP Delagrange D	1996	Curr Opin Lipidol1996，7，：	1
10	Dietary vitamin C and beta-carotene and risk of death in middle-aged men-the western electric study 显示文摘	PANDEY D K SHEKELLE R SELWYN B J	1995	Am J Epidemiol1995，142，12：	1
11	Neovascularisation is the principal cause of varicose vein recurrence:results of a randomized trial of stripping the long saphenous vein显示文摘	Jones L Braithwaite BD Selwyn D	1996	Eur J Vasc Endovasc Surg1996，12，4：	1
12	Risk factors forhuman immunodeficiency virus infection in intravenous drug users显示文摘	Schoenbaum EE Hartel D Selwyn PA	1989	N Engl J Med1989，321，13：	1
13	Patterns of cell death in freshwater colonial cyanobacteria during the late summer bloom显示文摘	SIGEE D C SELWYN A GALLOIS P	2007	Phycologia2007，46，3：	1
14	Biological mechanisms for the clinical success of lipid lowering in coronary artery disease and the use of surrogate and points显示文摘	Kinlay S Selwyn AP Delagrange D	1996	Cur Opin Lipidol1996，7，：	1
15	Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end points显示文摘	Kinlay S Selwyn AP Delagrange D	1996	Curr Opin Lipidol1996，7，：	1
16	Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points 显示文摘	Kinlay S Selwyn AP Delagrange D	1996	Curr Opin Lipidol1996，7，6：	1
17	Low molecular-weight heparin for anticoagulation during continuous venovenous hemofiltration显示文摘	Knight DJ Selwyn D Girling K	2003	Arch Intern Med2003，163，：	1
18	A prospective study of the risk of tuberculosis among intravenous drug users with human im- munodeficiency virus infection 显示文摘	Selwyn PA Hartel D Lewis VA	1989	N Engl J Med1989，320，9：	1
19	Highly Qualified Teachers: NCLB and Teacher Education显示文摘	Selwyn D	2007	Journal of Teacher Education2007，，2：	1
20	Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use ofsurrogate end points 显示文摘	KINLAY S SELWYN A P DELAGRANGE D	1996	Curr Opin Lipidol1996，7，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示